Compare PGEN & CDRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | CDRE |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2013 | 2021 |
| Metric | PGEN | CDRE |
|---|---|---|
| Price | $3.10 | $32.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $7.67 | ★ $39.67 |
| AVG Volume (30 Days) | ★ 3.4M | 380.7K |
| Earning Date | 03-25-2026 | 03-10-2026 |
| Dividend Yield | N/A | ★ 1.25% |
| EPS Growth | N/A | ★ 13.33 |
| EPS | N/A | ★ 1.02 |
| Revenue | $230,981,000.00 | ★ $610,308,000.00 |
| Revenue This Year | $342.78 | $23.72 |
| Revenue Next Year | $478.46 | $6.89 |
| P/E Ratio | ★ N/A | $31.30 |
| Revenue Growth | N/A | ★ 7.53 |
| 52 Week Low | $1.11 | $27.07 |
| 52 Week High | $5.47 | $48.76 |
| Indicator | PGEN | CDRE |
|---|---|---|
| Relative Strength Index (RSI) | 33.67 | 31.75 |
| Support Level | $2.99 | $31.58 |
| Resistance Level | $5.10 | $33.82 |
| Average True Range (ATR) | 0.17 | 2.02 |
| MACD | -0.00 | -0.48 |
| Stochastic Oscillator | 10.83 | 10.14 |
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.